OTC Pharmaceuticals in China

Date: September 27, 2016
Pages: 34
Price:
US$ 350.00
License [?]:
Publisher: MarketLine
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: OF0292BA8C6EN
Leaflet:

Download PDF Leaflet

OTC Pharmaceuticals in China
SUMMARY

OTC Pharmaceuticals in China industry profile provides top-line qualitative and quantitative summary information including: market share, market size (value 2011-15, and forecast to 2020). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.

KEY FINDINGS
  • Save time carrying out entry-level research by identifying the size, growth, major segments, and leading players in the otc pharmaceuticals market in China
  • Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the otc pharmaceuticals market in China
  • Leading company profiles reveal details of key otc pharmaceuticals market players' global operations and financial performance
  • Add weight to presentations and pitches by understanding the future growth prospects of the China otc pharmaceuticals market with five year forecasts
SYNOPSIS

Essential resource for top-line data and analysis covering the China otc pharmaceuticals market. Includes market size and segmentation data, textual and graphical analysis of market growth trends, leading companies and macroeconomic information.

REASONS TO BUY
  • What was the size of the China otc pharmaceuticals market by value in 2015?
  • What will be the size of the China otc pharmaceuticals market in 2020?
  • What factors are affecting the strength of competition in the China otc pharmaceuticals market?
  • How has the market performed over the last five years?
  • Who are the top competitors in China's otc pharmaceuticals market?
KEY HIGHLIGHTS

The OTC pharmaceuticals market consists of the retail sale of traditional medicines, cough and cold preparations (tablets, mixtures, lozenges, topical remedies, inhalers), vitamins and minerals (multi-vitamins, single minerals, single vitamins, tonics, cod liver oil), indigestion preparations (tablets, powders, mixtures), analgesics (Paracetamol, Ibuprofen, Aspirin and other analgesics), medicated skin products (anti-bacterials, acne treatments, anti-fungal, disinfectants and other), topical OTC medicines (anesthetic products, anti-itch products, antibiotic creams/gels), plasters and bandages (adhesive bandages/plasters, first aid tape, gauze pads/rolled gauze, liquid bandages and other tape or bandage), first aid kits and other (anti-smoking aids, rectal medications, eye/ear drops, sleeping aids, and motion sickness). The market is valued according to retail selling price (RSP) and includes any applicable taxes. Any currency conversions used in the creation of this report have been calculated using constant 2015 annual average exchange rates.

The Chinese OTC Pharmaceuticals market generated total revenues of $19,005.3m in 2015, representing a compound annual growth rate (CAGR) of 6.2% between 2011 and 2015.

Traditional medicines registered the highest sales value in the Chinese OTC pharmaceuticals market in 2015, with total sales of $7,717.8m, equivalent to 40.6% of the market's overall value.

China's large ageing population and inequity in healthcare provision may be behind the strong growth.
Executive Summary
Market value
Market value forecast
Category segmentation
Geography segmentation
Market share
Market rivalry
Market Overview
Market definition
Market analysis
Market Data
Market value
Market Segmentation
Category segmentation
Geography segmentation
Market share
Market distribution
Market Outlook
Market value forecast
Five Forces Analysis
Summary
Buyer power
Supplier power
New entrants
Threat of substitutes
Degree of rivalry
Leading Companies
GlaxoSmithKline Plc
Huangshan Tianmu Pharmaceutical Co., Ltd.
Johnson and Johnson
Nin Jiom Medicines Manufactory Ltd
Macroeconomic Indicators
Country data
Methodology
Industry associations
Related MarketLine research
Appendix
About MarketLine

LIST OF TABLES

Table 1: China OTC pharmaceuticals market value: $ million, 2011-15
Table 2: China OTC pharmaceuticals market category segmentation: $ million, 2015
Table 3: China OTC pharmaceuticals market geography segmentation: $ million, 2015
Table 4: China OTC pharmaceuticals market share: % share, by value, 2015
Table 5: China OTC pharmaceuticals market distribution: % share, by value, 2015
Table 6: China OTC pharmaceuticals market value forecast: $ million, 2015-20
Table 7: GlaxoSmithKline Plc: key facts
Table 8: GlaxoSmithKline Plc: key financials ($)
Table 9: GlaxoSmithKline Plc: key financials (£)
Table 10: GlaxoSmithKline Plc: key financial ratios
Table 11: Huangshan Tianmu Pharmaceutical Co., Ltd.: key facts
Table 12: Johnson and Johnson: key facts
Table 13: Johnson and Johnson: key financials ($)
Table 14: Johnson and Johnson: key financial ratios
Table 15: Nin Jiom Medicines Manufactory Ltd: key facts
Table 16: China size of population (million), 2011-15
Table 17: China gdp (constant 2005 prices, $ billion), 2011-15
Table 18: China gdp (current prices, $ billion), 2011-15
Table 19: China inflation, 2011-15
Table 20: China consumer price index (absolute), 2011-15
Table 21: China exchange rate, 2011-15

LIST OF FIGURES

Figure 1: China OTC pharmaceuticals market value: $ million, 2011-15
Figure 2: China OTC pharmaceuticals market category segmentation: % share, by value, 2015
Figure 3: China OTC pharmaceuticals market geography segmentation: % share, by value, 2015
Figure 4: China OTC pharmaceuticals market share: % share, by value, 2015
Figure 5: China OTC pharmaceuticals market distribution: % share, by value, 2015
Figure 6: China OTC pharmaceuticals market value forecast: $ million, 2015-20
Figure 7: Forces driving competition in the OTC pharmaceuticals market in China, 2015
Figure 8: Drivers of buyer power in the OTC pharmaceuticals market in China, 2015
Figure 9: Drivers of supplier power in the OTC pharmaceuticals market in China, 2015
Figure 10: Factors influencing the likelihood of new entrants in the OTC pharmaceuticals market in China, 2015
Figure 11: Factors influencing the threat of substitutes in the OTC pharmaceuticals market in China, 2015
Figure 12: Drivers of degree of rivalry in the OTC pharmaceuticals market in China, 2015
Figure 13: GlaxoSmithKline Plc: revenues and profitability
Figure 14: GlaxoSmithKline Plc: assets and liabilities
Figure 15: Johnson and Johnson: revenues and profitability
Figure 16: Johnson and Johnson: assets and liabilities

COMPANIES MENTIONED

GlaxoSmithKline Plc
Huangshan Tianmu Pharmaceutical Co., Ltd.
Johnson and Johnson
Nin Jiom Medicines Manufactory Ltd
Skip to top


OTC Pharmaceuticals Global Industry Almanac_2016 US$ 2,995.00 Oct, 2016 · 491 pages
OTC Pharmaceuticals Global Industry Guide_2016 US$ 1,495.00 Oct, 2016 · 271 pages
OTC Pharmaceuticals in Taiwan US$ 350.00 Sep, 2014 · 36 pages

Ask Your Question

OTC Pharmaceuticals in China
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry:
Please click on a Check Box below to confirm you are not a robot: